Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of a Basic Skin Care Product on the Structural Strength of the Skin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03625167
Recruitment Status : Completed
First Posted : August 10, 2018
Last Update Posted : January 23, 2019
Sponsor:
Information provided by (Responsible Party):
PD Dr. Jan Kottner, Charite University, Berlin, Germany

Brief Summary:
The main aim of this study is to investigate in a suction blister model, whether the use of a basic skin care formulation increases the mechanical integrity/adhesion of the dermo-epidermal junction.

Condition or disease Intervention/treatment Phase
Healthy Skin Other: Treatment with petrolatum Not Applicable

Detailed Description:

The process of aging involves numerous structural and functional changes also affecting the skin. The skin fulfills a variety of protective and regulatory functions. Compared to other organs, the skin is constantly exposed to harmful environmental influences. Besides intrinsic factors these external factors may accelerate skin aging. Due to its ageing-related loss of functional capacity the skin becomes susceptible to develop adverse skin conditions and dermatological diseases (e.g. skin dryness, fungal infections). Especially old aged, care depended, and severely ill individuals are at high risk for developing severe skin injuries and wounds (e.g. decubitus, skin tears) with high social and economic impact. Empirical evidence indicates that the reduced adhesion of the dermal-epidermal junction is a major pathophysiological predictor for these types of injuries.

The suction blister model is an artificial and controlled technique for dermal-epidermal separation along the dermo-epidermal junction (DEJ). Empirical evidence suggests that the time of the dermal-epidermal separation (blistering time) is a measure of the dermo-epidermal adhesion. It has been proposed that the blistering time might be a clinically relevant parameter reflecting the mechanical integrity/stability of the dermo-epidermal junction.

Clinical practice guidelines recommend the use of topical skin care products to reduce the risk for pressure ulcer and skin tear development. However, the underlying working mechanisms of most basic skin care products are poorly understood. It is known that topically applied skin care products exhibit physical and chemical effects on and in the uppermost skin layers (e.g. the stratum corneum). Despite a few well known active ingredients (e.g. retinoids, vitamin C) exhibiting effects in the dermis, a particular skin protective effect of the vast majority of daily basic skin care applications on these deeper skin layers is unknown. The primary objective of this study is to test, whether the use of a basic skin care formulation increases the mechanical integrity/adhesion of the dermo-epidermal junction.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: An Exploratory Randomized Controlled Study to Evaluate the Effect of a Basic Skin Care Product on the Structural Strength of the Dermo-epidermal Junction
Actual Study Start Date : July 31, 2018
Actual Primary Completion Date : December 11, 2018
Actual Study Completion Date : December 31, 2018

Resource links provided by the National Library of Medicine

Drug Information available for: Petrolatum

Arm Intervention/treatment
Experimental: Treatment with petrolatum
In each healthy volunteer, one of the two forearms is randomly assigned to the intervention. This forearm is treated with petrolatum for 4 respectively 8 weeks.
Other: Treatment with petrolatum
Petrolatum is applied twice daily to the intervention arm.

No Intervention: Control
The control forearm will remain untreated throughout the study.



Primary Outcome Measures :
  1. Blistering Time at Day 28±2 [ Time Frame: Day 28±2 ]
    Duration from the start of suction pressure to the development of a full blister (measured in minutes)

  2. Blistering Time at Day 56±2 [ Time Frame: Day 56±2 ]
    Duration from the start of suction pressure to the development of a full blister (measured in minutes)


Secondary Outcome Measures :
  1. Change from Baseline in Epidermal Thickness [ Time Frame: Baseline, Day 14±1, Day 28±2, Day 42±2, Day 56±2, Day 66±3 ]
    Optical coherence tomography (OCT) will be used to quantitatively measure changes of the epidermal thickness on the volar forearm

  2. Change from Baseline in Epidermal Hydratation, Measurements Per Skin Area in Percentage (%) at the volar forearm [ Time Frame: Baseline, Day 14±1, Day 28±2, Day 42±2, Day 56±2, Day 66±3 ]
    Epidermal moisture (measurement depth 0,5mm) was measured using MoistureMeterEpiD (Delfin Technologies Ltd.). The values are expressed in percentage of local tissue water (0 to 100 %).

  3. Change from Baseline in Stratum Corneum Hydration (SCH), measured in Arbitrary Units (AU) [ Time Frame: Baseline, Day 14±1, Day 28±2, Day 42±2, Day 56±2, Day 66±3 ]
    Corneometer® CM 825 (Courage & Khazaka electronic GmbH, Cologne, Germany) was used to measure Stratum Corneum Hydration (SCH) in arbitrary units (AU) (range 0-120 AU) on the volar forearm. Lower values represent reduced skin hydration in the upper skin layer.

  4. Skin surface Temperature [ Time Frame: Day 28±2 ]
    Measurement of the skin surface temperature on the volar forearm

  5. Skin surface Temperature [ Time Frame: Day 56±2 ]
    Measurement of the skin surface temperature on the volar forearm



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years to 85 Years   (Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy volunteers and/or with stable chronic condition (e.g. controlled hypertension)
  • Female,
  • 65 to 85 years,
  • Caucasian,
  • Phototype I to III according to the Fitzpatrick classification,
  • Body Mass Index between 20 and 28 kg/m2,
  • Non-smoker of at least one year,
  • Absence of skin diseases or scars in the skin area of interest,
  • Absence of tattoos in the skin area of interest,
  • Able to give written informed consent,
  • Willing and able to fulfill the study requirements

Exclusion Criteria:

  • Known or suspected defect of healing,
  • Diabetes mellitus
  • Any acute or chronic pathology that may interfere with the trial conduct, from investigator point of view,
  • Acute or chronic wounds in the skin area of interest,
  • Any skin affection which may interfere with the trial assessment, like urticaria,, psoriasis or scar on investigational areas,
  • Medical history of skin cancer,
  • History or establishment of diabetes or pre-diabetes,
  • Any hyper-sensibility to one of the compounds of the investigational product,
  • Any regular treatment which may affect the blood coagulation and hemostasis (anticoagulant medications, NSAID, etc.) before the suction blister induction (Visit 3 and Visit 5), one NSAID to treat headache within four days is allowed
  • Any physical treatment (like laser or surgery) on the arms within the last 6 months,
  • Use of topical or systemic treatment on the investigational areas within the past 4 weeks (topical hyaluronan, anti-inflammatory drugs, corticoids, retinoids, vitamin C, etc.) that would interfere with assessment and/or investigational treatments,
  • Allergy to band-aid or to metals (such as nickel),
  • UV sessions or strong sun exposure of the arms during the study period,
  • Subject who cannot be contacted easily in case of necessity,
  • Current participation in any other clinical study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03625167


Locations
Layout table for location information
Germany
Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergy, Charite University Berlin
Berlin, Germany, 10117
Sponsors and Collaborators
PD Dr. Jan Kottner
Investigators
Layout table for investigator information
Principal Investigator: Jan Kottner, PhD Charite University, Berlin, Germany

Layout table for additonal information
Responsible Party: PD Dr. Jan Kottner, Scientific Director Clinical Research Center for Hair and Skin Science, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier: NCT03625167    
Other Study ID Numbers: CRC-SP-A31
First Posted: August 10, 2018    Key Record Dates
Last Update Posted: January 23, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by PD Dr. Jan Kottner, Charite University, Berlin, Germany:
skin ageing
suction blister
dermo-epidermal junction
Additional relevant MeSH terms:
Layout table for MeSH terms
Petrolatum
Emollients
Dermatologic Agents